You might want to read it again. Because the letter doesn't say it's being dropped for "Lipid Lowering." It doesn't give any reason.
All it says is that it will no longer be covered starting May 1st. You're assuming the patient isn't prescribed V for CVD indication. The letter says nothing to differentiate the 2 labels as stated in my previous post.
Market Data 
Markets 
AI
